Antioxidant-Enhanced Polypeptide Production via Redox Control

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current methods for expressing recombinant proteins are time-consuming and result in protein loss, increasing production costs due to the difficulty in producing sufficient amounts for commercial use, particularly in recombinant host systems that require purification before therapeutic use.

Innovation Solution

Increasing antioxidant levels within cells expressing target polypeptides, either through direct introduction of antioxidants or genetic engineering to enhance antioxidant biosynthesis, which enhances protein production, stability, and activity, allowing for higher yields and improved post-translational modifications.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Productivity

If recombinant protein expression is performed in heterologous systems, then protein production can be achieved, but production amounts are insufficient for commercial use and require time-consuming purification steps

Engineering Contradiction:
Improverecombinant protein production amountVSAvoidpurification time
Core Design Contradiction:
ProductivityVSLoss of time

Solution Approach 1:

The patent employs a self-cleaving peptide sequence (such as enterokinase recognition sequence or other protease cleavage sites) that automatically cleaves the fusion protein under specific conditions, eliminating the need for external purification enzymes or complex purification procedures. The target protein self-releases from the fusion construct, providing a simple, time-efficient solution that maintains high production amounts while dramatically reducing purification time and cost

Inventive Principle:
Principle #25Self-service

2Productivity

If protein expression levels are increased to meet commercial requirements, then production amounts improve, but protein stability and activity decrease due to oxidative stress

Engineering Contradiction:
Improvetarget polypeptide production levelVSAvoidprotein stability and activity
Core Design Contradiction:
ProductivityVSReliability

Solution Approach 1:

The patent introduces antioxidant molecules (such as ascorbic acid, glutathione, or other reducing agents) as intermediary substances that mediate between the high-expression state and protein stability. These antioxidants act as protective intermediaries that scavenge reactive oxygen species generated during high-level expression, thereby maintaining protein stability and activity without compromising production levels

Inventive Principle:
Principle #24Intermediary (Mediator)

Solution Approach 2:

The patent modifies the redox parameter of the cellular environment by introducing antioxidants that shift the oxidation-reduction balance toward a more reducing state. This parameter change protects proteins from oxidative damage while allowing high expression levels to be maintained, effectively decoupling the trade-off between productivity and reliability

Inventive Principle:
Principle #35Parameter changes

3Productivity

If fusion protein constructs are used to enhance expression, then production levels increase, but additional purification steps are required

Engineering Contradiction:
Improvepolypeptide production levelVSAvoidpurification process complexity
Core Design Contradiction:
ProductivityVSDevice complexity

Solution Approach 1:

The patent strategically extracts or removes the purification burden by using a self-cleaving peptide sequence that automatically separates the target protein from the fusion construct. This eliminates the need for additional purification steps such as affinity chromatography or enzymatic cleavage, thereby maintaining high production levels while simplifying the purification process to minimal steps

Inventive Principle:
Principle #2Taking out (Extraction)

Data Source

PatentUS11773399B2Methods and compositions for enhancing polypeptide production
Publication Date: 2023.10.03 ARKANSAS STATE UNIV
  • US11773399B2 patent drawing
  • US11773399B2 patent drawing
  • US11773399B2 patent drawing

AI summary

Methods of increasing production, stability or activity of a target polypeptide are provided herein. The method includes increasing the level of an antioxidant in a cell comprising a polynucleotide encoding the target polypeptide. Also provided are cells and transgenic organisms produced using the methods described herein. Methods of treating a subject with a condition treatable by administration of the target polypeptide are also disclosed. Finally methods and compositions for transiently increasing antioxidants in plant cells are provided.